SY03 – Hepatic Encephalopathy: tHE Pathway to Quality Care
Provided by the Chronic Liver Disease Foundation, supported by an education grant from Salix Pharmaceuticals.
STATEMENT OF NEED
The lecture will focus on the coordinated application of a CLDF endorsed evidence-based algorithm in the in-patient and ambulatory setting with the goal of improving patient outcomes.
Upon completion of this educational activity, participants should be able to:
• Communicate the prevalence of HE and define the complications and consequences associated with chronic liver disease, with focus on HE
• Identify the importance of early recognition of and screening for HE and describe the screening methods
• Describe the economic, patient and caregiver burdens associated with cirrhosis and HE
• Apply techniques to properly treat HE patients, including strategies for successfully transitioning patients from inpatient HE care to outpatient HE care in order to prevent disease recurrence and hospital readmissions